{
    "Trade/Device Name(s)": [
        "CareSens N LINK Blood Glucose Monitoring System",
        "CareSens N LINK Multi Blood Glucose Monitoring System"
    ],
    "Submitter Information": "i-SENS, Inc.",
    "510(k) Number": "K130696",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083468"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "August 21, 2013",
    "Summary Letter Received Date": "July 11, 2013",
    "Submission Date": "July 10, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "CareSens N LINK Blood Glucose Meter",
        "CareSens N LINK Multi Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometric method",
        "Glucose oxidase (Aspergillus sp.)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for CareSens N LINK and CareSens N LINK Multi Blood Glucose Monitoring Systems using electrochemical biosensor technology for quantitative glucose measurement in whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertips and alternative sites; CareSens N LINK for single-person self-testing at home, CareSens N LINK Multi for multiple-patient professional healthcare settings, both as aids to monitor effectiveness of diabetes control, not for neonates or diabetes diagnosis.",
    "fda_folder": "Clinical Chemistry"
}